Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viatris Inc (VTRS)

Viatris Inc (VTRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,943,785
  • Shares Outstanding, K 1,193,593
  • Annual Sales, $ 15,427 M
  • Annual Income, $ 54,700 K
  • EBIT $ -265 M
  • EBITDA $ 2,476 M
  • 60-Month Beta 0.96
  • Price/Sales 0.94
  • Price/Cash Flow 2.32
  • Price/Book 0.73

Options Overview Details

View History
  • Implied Volatility 30.73% ( -4.55%)
  • Historical Volatility 23.15%
  • IV Percentile 55%
  • IV Rank 45.96%
  • IV High 42.39% on 10/31/24
  • IV Low 20.82% on 11/13/24
  • Put/Call Vol Ratio 0.94
  • Today's Volume 2,474
  • Volume Avg (30-Day) 1,491
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 112,471
  • Open Int (30-Day) 107,618

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.58
  • Number of Estimates 4
  • High Estimate 0.60
  • Low Estimate 0.55
  • Prior Year 0.61
  • Growth Rate Est. (year over year) -4.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.07 +3.73%
on 12/19/24
13.55 -7.60%
on 11/25/24
-0.61 (-4.65%)
since 11/20/24
3-Month
11.19 +11.89%
on 09/26/24
13.55 -7.60%
on 11/25/24
+1.13 (+9.92%)
since 09/20/24
52-Week
9.93 +26.15%
on 06/18/24
13.62 -8.06%
on 02/23/24
+2.07 (+19.81%)
since 12/20/23

Most Recent Stories

More News
2 Generic Drug Stocks Ready to Surge in 2025

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

LXRX : 0.7147 (-1.23%)
VTRS : 12.52 (+3.22%)
TEVA : 22.09 (+3.66%)
AMGN : 263.38 (+0.84%)
PFE : 26.36 (+2.29%)
Viatris: Q3 Earnings Snapshot

Viatris: Q3 Earnings Snapshot

VTRS : 12.52 (+3.22%)
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?

Due to Viatris’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain cautious about the stock’s prospects.

XPH : 43.42 (+0.39%)
$SPX : 5,930.85 (+1.09%)
VTRS : 12.52 (+3.22%)
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies due to report their third-quarter 2024 results this week.The remaining large...

NVO : 85.00 (-17.83%)
VTRS : 12.52 (+3.22%)
TEVA : 22.09 (+3.66%)
GILD : 92.57 (+1.62%)
MRNA : 39.39 (-0.43%)
Earnings Preview: What to Expect From Viatris' Report

Viatris is all set to announce its third-quarter results next month, with analysts predicting a double-digit decline in the company's earnings.

XLV : 138.00 (+1.26%)
$SPX : 5,930.85 (+1.09%)
VTRS : 12.52 (+3.22%)
Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

LXRX : 0.7147 (-1.23%)
VTRS : 12.52 (+3.22%)
How To Spot Good Value Stocks In A Sea Of Noise

Explore why traditional value investing often falls short and how catalysts can transform undervalued stocks into lucrative investments.

CTVA : 57.48 (+2.35%)
VTRS : 12.52 (+3.22%)
PFE : 26.36 (+2.29%)
AMZN : 224.92 (+0.73%)
GE : 168.37 (+2.17%)
The Hidden Power Of Spinoffs: Why They Continue To Outperform

CVS just announced it was considering a breakup. Why is that important? Spinoffs are one of the best-kept investment secrets, despite the fact that many investors typically disregard them and frequently...

PYPL : 87.13 (+0.40%)
CVS : 44.36 (+1.32%)
MDLZ : 59.39 (+0.20%)
TRIP : 13.79 (-0.72%)
COP : 95.12 (-0.06%)
KHC : 30.52 (+1.40%)
EXPE : 184.75 (+2.98%)
HLN : 9.69 (-0.10%)
PFE : 26.36 (+2.29%)
PSX : 110.37 (+0.02%)
EBAY : 65.01 (+1.66%)
VTRS : 12.52 (+3.22%)
Is Viatris Stock Underperforming the Dow?

Viatris has underperformed the Dow Jones Industrial Average over the past year, and analysts remain cautious about the stock’s prospects.

VTRS : 12.52 (+3.22%)
$DOWI : 42,840.26 (+1.18%)
SNY : 47.71 (+0.44%)
Do Options Traders Know Something About Viatris (VTRS) Stock We Don't?

Investors in Viatris Inc. VTRS need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $3 Call had some of the highest implied volatility...

VTRS : 12.52 (+3.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor...

See More

Key Turning Points

3rd Resistance Point 13.10
2nd Resistance Point 12.83
1st Resistance Point 12.68
Last Price 12.52
1st Support Level 12.25
2nd Support Level 11.98
3rd Support Level 11.83

See More

52-Week High 13.62
Last Price 12.52
Fibonacci 61.8% 12.21
Fibonacci 50% 11.77
Fibonacci 38.2% 11.34
52-Week Low 9.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar